Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Cholecystitis

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy and safety of infliximab in patients with autoimmune hepatitis.

Hepatology (Baltimore, Md.)·2024

Same author

N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review.

Frontiers in pharmacology·2022

Same author

A retrospective analysis of the duration of mechanical ventilation in Scandinavian paediatric heart centres.

Acta paediatrica (Oslo, Norway : 1992)·2022

Same author

Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.

Journal of hepatology·2021

Same author

Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.

Liver international : official journal of the International Association for the Study of the Liver·2021

Same author

Becoming an Expert by Experience: Benefits and Challenges of Educating Mental Health Nursing Students.

Issues in mental health nursing·2021

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision

Published on: May 2, 2025

Small-duct primary sclerosing cholangitis.

Einar Björnsson¹

¹Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Med pol II, SE-413 45 Gothenburg, Sweden. einar.bjornsson@medic.gu.se

Current Gastroenterology Reports

|January 27, 2009

Summary

This summary is machine-generated.

Small-duct primary sclerosing cholangitis (PSC) patients show a better prognosis than large-duct PSC, but some still face liver complications or transplant needs. Cholangiocarcinoma is not seen in small-duct PSC without progression to large-duct PSC.

Related Experiment Videos

Last Updated: Jun 26, 2026

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision

Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision

Published on: May 2, 2025

Area of Science:

Hepatology
Gastroenterology
Immunology

Background:

Small-duct primary sclerosing cholangitis (PSC) is a subgroup of PSC characterized by cholestatic liver tests and typical histology but a normal cholangiogram.
This subgroup has been less extensively studied compared to the classic large-duct form of PSC.
Previous studies suggested a better prognosis for small-duct PSC, but were limited by small cohorts and short follow-up periods.

Purpose of the Study:

To further characterize the clinical course and long-term outcomes of patients with small-duct PSC.
To confirm or refute earlier findings regarding the prognosis of small-duct PSC compared to large-duct PSC.
To investigate the risk of complications such as liver transplantation and cholangiocarcinoma in small-duct PSC.

Main Methods:

Combined data from multiple previous studies to create a larger cohort of small-duct PSC patients.
Extended patient follow-up to assess long-term outcomes.
Analysis of liver-related mortality, need for liver transplantation, and occurrence of cholangiocarcinoma.

Main Results:

Prolonged follow-up of a combined cohort confirmed a generally better prognosis for small-duct PSC compared to large-duct PSC.
Despite the better prognosis, a subset of small-duct PSC patients experienced liver-related mortality or required liver transplantation.
Recurrence of small-duct PSC post-liver transplantation was observed.
Cholangiocarcinoma has not been reported in small-duct PSC patients unless they progressed to large-duct PSC.

Conclusions:

Small-duct PSC generally has a favorable prognosis, but careful monitoring for potential complications is warranted.
Progression to large-duct PSC may be a prerequisite for developing cholangiocarcinoma in patients initially diagnosed with small-duct PSC.
Further research is needed to fully understand the long-term implications and management strategies for small-duct PSC.